NASDAQ:WALD - Nasdaq - JE00BPG99318 - Common Stock - Currency: USD
3.16
-0.03 (-0.94%)
The current stock price of WALD is 3.16 USD. In the past month the price decreased by -4.53%. In the past year, price decreased by -52.48%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.29 | 138.82B | ||
HLN | HALEON PLC-ADR | 23.44 | 45.58B | ||
KVUE | KENVUE INC | 20.46 | 44.71B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 30.3 | 25.83B | ||
BRBR | BELLRING BRANDS INC | 35.08 | 9.36B | ||
COTY | COTY INC-CL A | 20.39 | 4.98B | ||
IPAR | INTERPARFUMS INC | 28.81 | 4.30B | ||
ELF | ELF BEAUTY INC | 23.86 | 4.23B | ||
ODD | ODDITY TECH LTD-CL A | 22.92 | 2.51B | ||
EPC | EDGEWELL PERSONAL CARE CO | 10.64 | 1.50B | ||
OLPX | OLAPLEX HOLDINGS INC | 10.92 | 941.35M | ||
HLF | HERBALIFE LTD | 4.24 | 837.56M |
Waldencast Plc develops and operates a beauty and wellness platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. The company is headquartered in White Plains, New York and currently employs 281 full-time employees. The company went IPO on 2021-03-18. The company is focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. Its segments include Obagi Medical and Milk Makeup. The Obagi Medical is an advanced skin care line rooted in research and skin biology. The company provides treatment of hyperpigmentation with the Obagi Medical Nu-Derm System. The Obagi Medical products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. The Milk Makeup segment is a makeup brand, which offers a selection of both makeup and skincare products. Its products include Matte Bronzer, Hydro Grip Set + Refresh Spray, Kush Mascara, Kush Brow and Pore Eclipse Primer. Milk Makeup offers over 300 products through its United States Website, www.MilkMakeup.com, and its retail partners, including Sephora in North America, Europe, the Middle East and Australia and Cult Beauty and Selfridges in the United Kingdom.
WALDENCAST PLC-A
10 Bank Street, Suite 560
White Plains NEW YORK US
CEO: Michel Brousset
Employees: 284
Company Website: https://www.waldencast.com/
Investor Relations: https://ir.waldencast.com/
Phone: 19175466828
The current stock price of WALD is 3.16 USD. The price decreased by -0.94% in the last trading session.
The exchange symbol of WALDENCAST PLC-A is WALD and it is listed on the Nasdaq exchange.
WALD stock is listed on the Nasdaq exchange.
12 analysts have analysed WALD and the average price target is 5.88 USD. This implies a price increase of 85.92% is expected in the next year compared to the current price of 3.16. Check the WALDENCAST PLC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
WALDENCAST PLC-A (WALD) has a market capitalization of 388.21M USD. This makes WALD a Small Cap stock.
WALDENCAST PLC-A (WALD) currently has 284 employees.
WALDENCAST PLC-A (WALD) has a support level at 3.02 and a resistance level at 3.55. Check the full technical report for a detailed analysis of WALD support and resistance levels.
The Revenue of WALDENCAST PLC-A (WALD) is expected to decline by -2.48% in the next year. Check the estimates tab for more information on the WALD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
WALD does not pay a dividend.
WALDENCAST PLC-A (WALD) will report earnings on 2025-03-18, after the market close.
WALDENCAST PLC-A (WALD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.99).
The outstanding short interest for WALDENCAST PLC-A (WALD) is 0.65% of its float. Check the ownership tab for more information on the WALD short interest.
ChartMill assigns a technical rating of 1 / 10 to WALD. When comparing the yearly performance of all stocks, WALD is a bad performer in the overall market: 89.85% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to WALD. WALD may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months WALD reported a non-GAAP Earnings per Share(EPS) of -0.99. The EPS increased by 26.82% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -8.88% | ||
ROE | -14.55% | ||
Debt/Equity | 0.23 |
ChartMill assigns a Buy % Consensus number of 80% to WALD. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of -292.38% and a revenue growth -2.48% for WALD